Semglee

Indicated For

Diabetes

About This Medication

# Viatris Patient Assistance Program Patient Guide: How to Get Semglee (insulin glargine-yfgn) at Low or No Cost Semglee (insulin glargine-yfgn) is an affordable, interchangeable biosimilar to **Lantus**, a long-acting insulin used to help control blood sugar levels in adults and children with **type 1 diabetes** or adults with **type 2 diabetes**. The **Viatris Patient Assistance Program (PAP)** offers this medication **free of charge** to qualifying uninsured or underinsured U.S. residents who meet financial need criteria[1][2][3]. ## About Semglee and Why Assistance Matters **Semglee** is a prescription insulin that provides a steady release of insulin over 24 hours, helping maintain stable blood glucose levels between meals and overnight. It's administered via subcutaneous injection once daily and comes in pre-filled pens or vials. As a biosimilar, Semglee matches the efficacy, safety, and quality of its reference product but is typically **lower cost**, making it accessible for diabetes management[1]. Diabetes affects millions, and insulin is a lifelong necessity. Without insurance or with high costs, patients risk poor control, leading to complications like neuropathy, kidney disease, or heart issues. The Viatris PAP bridges this gap by providing **free Semglee** for up to **12 months** (with up to 11 refills) to eligible patients, easing financial burdens and supporting adherence[3][6]. ## Who Qualifies for the Program? Eligibility focuses on **financial need**, **residency**, **insurance status**, and a valid prescription. Key requirements include: - **U.S. resident** (including territories)[2][3]. - **Financial hardship**: Income must meet program thresholds (individually assessed; proof required)[1][2]. - **Uninsured or underinsured**: Fully uninsured preferred; no prescription drug coverage (Medicare Part D, Medicaid, etc., may disqualify unless specific state insulin programs apply)[2][3][4]. - Prescription for an **FDA-approved use** by a licensed U.S. healthcare provider[2]. **Note**: Medicare patients are generally ineligible due to prescription coverage requirements, but check state-specific insulin assistance (e.g., Colorado's Continuing Need State Insulin Program)[4]. ## Income Eligibility Breakdown Specific Federal Poverty Level (FPL) percentages or household size thresholds are not publicly detailed online; eligibility is **individually assessed** based on provided income proof. Common PAPs use 400-500% FPL, but Viatris evaluates case-by-case[1][2]. | Household Size | Estimated Max Annual Income (Example at 400% FPL)* | Notes | |---------------|---------------------------------------------------|-------| | Individual | ~$58,320 | Proof like tax returns required[2] | | Couple | ~$78,880 | Household income combined | | Family of 3 | ~$99,440 | Includes dependents | | Family of 4 | ~$120,000 | Add ~$20,560 per additional member | *Estimates for 2026 continental U.S. FPL; actual thresholds vary. Contact program for exact assessment[1]. ## Insurance Requirements - **Primary**: Must be **fully uninsured** or have **no prescription drug coverage** (e.g., no Medicare Part D, Medicaid, Tricare)[2][3][7]. - Underinsured patients may qualify if they lack drug coverage and meet income criteria[1]. - **Medicare**: Typically ineligible[4][9]. - Provider verifies status; incomplete info delays approval[2]. ## Step-by-Step Application Process The program supports **multiple application methods**: phone, fax, email, or online via Viatris site[1][2][4][5]. 1. **Confirm Eligibility**: Visit viatris.com, select Semglee, and check criteria. Call **(800) 796-9526** or **888-417-5782** (M-F, 8AM-5PM CST/EST) for questions[1][2][5]. 2. **Gather Documents**: - **Proof of income**: Recent tax return, pay stubs (last 3 months), W-2, or notarized statement[2][9]. - **Proof of insurance status**: Insurance denial letter or certification of no coverage[2]. - Prescription details from prescriber (name, NPI, signature)[2][3]. - Patient ID (SSN last 4 digits, DOB, address)[2]. 3. **Complete Application**: Download from viatris.com (insulin-specific form) or request by phone. Prescriber and patient must sign[2][4]. 4. **Submit**: - **Phone**: (800) 796-9526 or 888-417-5782[1][5]. - **Fax**: 866-792-7945, 877-427-7290, or insulin-specific[2][3][4]. - **Email**: ViatrisPAP@Cardinalhealth.com or ViatrisPAP@viatris.com[2][3]. - Online portal for some support[10]. 5. **Follow Up**: Program notifies within **5 business days** if more info needed; decision in **3 business days** after[4]. ## Timeline and Delivery - **Processing**: 3-5 business days post-complete submission[4]. - **Approval Duration**: 12 months, up to 11 refills[3][6]. - **Delivery**: Shipped free to **patient's home** or **physician's office**[1]. - **Reauthorization**: Required annually; resubmit proof[3]. Track via phone or portal[10]. ## Alternatives if Denied or Ineligible - **Biosimilar Alternative**: **Rezvoglar** (another insulin glargine option; check Viatris PAP)[provided]. - Other insulins: MySemglee savings card (if insured), NeedyMeds.org, RxAssist.org[5][7]. - State programs (e.g., Colorado insulin for insured)[4]. - Generic insulins or 340B clinics. ## Important Disclaimer This guide is for informational purposes based on available program details as of 2026. Eligibility, terms, and contacts may change; always verify with Viatris at (800) 796-9526 or viatris.com. Not medical advice—consult your doctor for treatment. Viatris PAP does not guarantee approval; applications are assessed individually[1][2]. Word count: 1028.

Program information last verified: March 30, 2026